Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.03.06.483172

PubMed Identifier: 35291294

Publication URI: http://europepmc.org/abstract/MED/35291294

Type: Journal Article/Review

Parent Publication: bioRxiv : the preprint server for biology